Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion type Assertion NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_head.
- NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion description "[These results validate myostatin inhibition as a therapeutic approach to muscle wasting diseases such as muscular dystrophy, sarcopenic frailty of the elderly and amylotrophic lateral sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_provenance.
- NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion evidence source_evidence_literature NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_provenance.
- NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion SIO_000772 16246158 NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_provenance.
- NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion wasDerivedFrom befree-20150227 NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_provenance.
- NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_assertion wasGeneratedBy ECO_0000203 NP422153.RAjAxMDhHu0bEWaJ85aBx-hkWneW9xEF7feAeVAzG5KDQ130_provenance.